Morphine: A protective or destructive role in neurons?

Neuroscientist

Volumn 14, Issue 6, 2008, Pages 561-570

  Zhang, Yan ^a   Chen, Qiuyue ^a   Yu, Long Chuan ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Apoptosis; Morphine; Neurons; Protection; Toxicity

Indexed keywords

ETORPHINE; MORPHINE; NALOXONE; OPIATE; OPIATE PEPTIDE;

ANTINOCICEPTION; APOPTOSIS; BRAIN NERVE CELL; CELL DEATH; CHRONIC PAIN; COMPREHENSION; DRUG DEPENDENCE; GLIA CELL; HUMAN; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; APOPTOSIS; HUMANS; MODELS, BIOLOGICAL; MORPHINE; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES;

EID: 47249127318     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858408314434     Document Type: Review

References (83)

1. Alexander M., Daniel T., Chaudry IH, Schwacha MG 2005. Opiate analgesics contribute to the development of post-injury immunosuppression. J Surg Res 129: 161-8.
2. Ammon S., Mayer P., Riechert U., Tischmeyer H., Hollt V. 2003. Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal. Brain Res Mol Brain Res 112 (1-2). 113-25.
3. Ammon-Treiber S., Grecksch G., Stumm R., Riechert U., Tischmeyer H., Reichenauer A., and others. 2004. Rapid, transient, and dose-dependent expression of hsp70 messenger RNA in the rat brain after morphine treatment. Cell Stress Chaperones 9: 182-97.
4. Ammon-Treiber S., Stolze D., Schroder H., Loh H., Hollt V. 2005. Effects of opioid antagonists and morphine in a hippocampal hypoxia/hypoglycemia model. Neuropharmacology 49: 1160-9.
5. Atici S., Cinel L., Cinel I., Doruk N., Aktekin M., Akca A., and others. 2004. Opioid neurotoxicity: comparison of morphine and tramadol in an experimental rat model. Int J Neurosci 114: 1001-11.
6. Bailey CP, Connor M. 2005. Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol 5: 60-8.
7. Barrere-Lemaire S., Combes N., Sportouch-Dukhan C., Richard S., Nargeot J., Piot C. 2005. Morphine mimics the antiapoptotic effect of preconditioning via an Ins(1,4,5)P3 signaling pathway in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 288: H83-8.
8. Benyhe S. 1994. Morphine: new aspects in the study of an ancient compound. Life Sci 55: 969-79.
9. Berg D., Becker G., Reiners K. 1999. Reduction of dyskinesia and induction of akinesia induced by morphine in two parkinsonian patients with severe sciatica. J Neural Transm 106 (7-8). 725-8.
10. Bodnar RJ 2007. Endogenous opiates and behavior: 2006. Peptides 28: 2435-513.
11. Cadet P., Rasmussen M., Zhu W., Tonnesen E., Mantione KJ, Stefano GB 2004. Endogenous morphinergic signaling and tumor growth. Front Biosci 9: 3176-86.
12. Calixto JB, Beirith A., Ferreira J., Santos AR, Filho VC, Yunes RA 2000. Naturally occurring antinociceptive substances from plants. Phytother Res 14: 401-18.
13. Casanova ML, Blazquez C., Martinez-Palacio J., Villanueva C., Fernandez-Acenero MJ, Huffman JW, and others. 2003. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest 111: 43-50.
14. Connor M., Osborne PB, Christie MJ 2004. Mu-opioid receptor desensitization: is morphine different ? Br J Pharmacol 143: 685-96.
15. Cunha-Oliveira T., Rego AC, Garrido J., Borges F., Macedo T., Oliveira CR 2007. Street heroin induces mitochondrial dysfunction and apoptosis in rat cortical neurons. J Neurochem 101: 543-54.
16. Dinda A., Gitman M., Singhal PC 2005. Immunomodulatory effect of morphine: therapeutic implications. Expert Opin Drug Saf 4: 669-75.
17. Eisch AJ, Mandyam CD 2007. Adult neurogenesis: can analysis of cell cycle proteins move us "Beyond BrdU "? Curr Pharm Biotechnol 8: 147-65.
18. Fan XL, Zhang JS, Zhang XQ, Ma L. 2003. Chronic morphine treatment and withdrawal induce up-regulation of c-Jun N-terminal kinase 3 gene expression in rat brain. Neuroscience 122: 997-1002.
19. Fanjun M., Junfa L., Bingxi Z., Fang J. 2006. nPKCepsilon and NMDA receptors participate in neuroprotection induced by morphine pretreatment. J Neurosurg Anesthesiol 18: 119-24.
20. Fattore L., Puddu MC, Picciau S., Cappai A., Fratta W., Serra GP, and others. 2002. Astroglial in vivo response to cocaine in mouse dentate gyrus: a quantitative and qualitative analysis by confocal microscopy. Neuroscience 110: 1-6.
21. Fishbein DH, Krupitsky E., Flannery BA, Langevin DJ, Bobashev G., Verbitskaya E., and others. 2007. Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use. Drug Alcohol Depend 90: 25-38.
22. Furst S. 1999. Transmitters involved in antinociception in the spinal cord. Brain Res Bull 48: 129-41.
23. Glasel JA 2000. The effects of morphine on cell proliferation. Prog Drug Res 55: 33-80.
24. Gralow I. 2002. Cancer pain: an update of pharmacological approaches in pain therapy. Curr Opin Anaesthesiol 15: 555-61.
25. Gross ER, Hsu AK, Gross GJ 2004. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res 94: 960-6.
26. Gross ER, Hsu AK, Gross GJ 2007. Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta. Diabetes 56: 127-36.
27. Gupta K., Kshirsagar S., Chang L., Schwartz R., Law PY, Yee D., and others. 2002. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 62: 4491-8.
28. Harburg GC, Hall FS, Harrist AV, Sora I., Uhl GR, Eisch AJ 2007. Knockout of the mu opioid receptor enhances the survival of adult-generated hippocampal granule cell neurons. Neuroscience 144: 77-87.
29. Hill MD, Cooper PW, Perry JR 2000. Chasing the dragon-neurological toxicity associated with inhalation of heroin vapour: case report. CMAJ 162: 236-8.
30. Hodgson PS, Neal JM, Pollock JE, Liu SS 1999. The neurotoxicity of drugs given intrathecally (spinal). Anesth Analg 88: 797-809.
31. Jaume M., Jacquet S., Cavailles P., Mace G., Stephan L., Blanpied C., and others. 2004. Opioid receptor blockade reduces Fas-induced hepatitis in mice. Hepatology 40: 1136-43.
32. Jiang Y., Yang W., Zhou Y., Ma L. 2003. Up-regulation of murine double minute clone 2 (MDM2) gene expression in rat brain after morphine, heroin, and cocaine administrations. Neurosci Lett 352: 216-20.
33. Johnson EE, Christie MJ, Connor M. 2005. The role of opioid receptor phosphorylation and trafficking in adaptations to persistent opioid treatment. Neurosignals 14: 290-302.
34. Khurdayan VK, Buch S., El-Hage N., Lutz SE, Goebel SM, Singh IN, and others. 2004. Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. Eur J Neurosci 19: 3171-82.
35. Kim MS, Cheong YP, So HS, Lee KM, Kim TY, Oh J., and others. 2001. Protective effects of morphine in peroxynitrite-induced apoptosis of primary rat neonatal astrocytes: potential involvement of G protein and phosphatidylinositol 3-kinase (PI3 kinase). Biochem Pharmacol 61: 779-86.
36. Kim YR, Lee SY, Shin BA, Kim KM 1999. Panax ginseng blocks morphine-induced thymic apoptosis by lowering plasma corticosterone level. Gen Pharmacol 32: 647-52.
37. Kovacic P. 2005. Unifying mechanism for addiction and toxicity of abused drugs with application to dopamine and glutamate mediators: electron transfer and reactive oxygen species. Med Hypotheses 65: 90-6.
38. Kugawa F., Arae K., Ueno A., Aoki M. 1998. Buprenorphine hydrochloride induces apoptosis in NG108-15 nerve cells. Eur J Pharmacol 347: 105-12.
39. Kugawa F., Ueno A., Aoki M. 2000. Apoptosis of NG108-15 cells induced by buprenorphine hydrochloride occurs via the caspase-3 pathway. Biol Pharm Bull 23: 930-5.
40. Li PF, Hao YS, Huang DA, Liu XH, Liu SL, Li G. 2004. Morphine-promoted survival of CEMx174 cells in early stages of SIV infection in vitro: involvement of the multiple molecular mechanisms. Toxicol In Vitro 18: 449-56.
41. Lin KF, Chang RC, Suen KC, So KF, Hugon J. 2004. Modulation of calcium/calmodulin kinase-II provides partial neuroprotection against beta-amyloid peptide toxicity. Eur J Neurosci 19: 2047-55.
42. Liu H., McPherson BC, Yao Z. 2001. Preconditioning attenuates apoptosis and necrosis: role of protein kinase C epsilon and -delta iso-forms. Am J Physiol Heart Circ Physiol 281: H404-10.
43. Liu Y., Wang Y., Jiang Z., Wan C., Zhou W., Wang Z. 2007. The extracellular signal-regulated kinase signaling pathway is involved in the modulation of morphine-induced reward by mPer1. Neuroscience 146: 265-71.
44. Lyeth BG, Liu S., Hamm RJ 1993. Combined scopolamine and morphine treatment of traumatic brain injury in the rat. Brain Res 617: 69-75.
45. Mao J., Sung B., Ji RR, Lim G. 2002. Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism. J Neurosci 22: 7650-61.
46. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE 1976. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197: 517-32.
47. Matthes HW, Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., and others. 1996. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383: 819-23.
48. Nestler EJ 2004. Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci 25: 210-8.
49. Pak T., Cadet P., Mantione KJ, Stefano GB 2005. Morphine via nitric oxide modulates beta-amyloid metabolism: a novel protective mechanism for Alzheimer's disease. Med Sci Monit 11: BR357-66.
50. Pasternak GW 2004. Multiple opiate receptors: déjà vu all over again. Neuropharmacology 47 (suppl 1). 312-23.
51. Patel J., Manjappa N., Bhat R., Mehrotra P., Bhaskaran M., Singhal PC 2003 a. Role of oxidative stress and heme oxygenase activity in morphine-induced glomerular epithelial cell growth. Am J Physiol Renal Physiol 285: F861-9.
52. Patel K., Bhaskaran M., Dani D., Reddy K., Singhal PC 2003 b. Role of heme oxygenase-1 in morphine-modulated apoptosis and migration of macrophages. J Infect Dis 187: 47-54.
53. Peart JN, Gross GJ 2004. Chronic exposure to morphine produces a marked cardioprotective phenotype in aged mouse hearts. Exp Gerontol 39: 1021-6.
54. Peart JN, Gross ER, Gross GJ 2005. Opioid-induced preconditioning: recent advances and future perspectives. Vascul Pharmacol 42 (5-6). 211-8.
55. Polakiewicz RD, Schieferl SM, Gingras AC, Sonenberg N., Comb MJ 1998. mu-Opioid receptor activates signaling pathways implicated in cell survival and translational control. J Biol Chem 273: 23534-41.
56. Qian L., Tan KS, Wei SJ, Wu HM, Xu Z., Wilson B., and others. 2007. Microglia-mediated neurotoxicity is inhibited by morphine through an opioid receptor-independent reduction of NADPH oxidase activity. J Immunol 179: 1198-209.
57. Raehal KM, Bohn LM 2005. Mu opioid receptor regulation and opiate responsiveness. AAPS J 7: E587-91.
58. Rambhia S., Mantione KJ, Stefano GB, Cadet P. 2005. Morphine modulation of the ubiquitin-proteasome complex is neuroprotective. Med Sci Monit 11: BR386-96.
59. Razaq M., Balicas M., Mankan N. 2007. Use of hydromorphone (Dilaudid) and morphine for patients with hepatic and renal impairment. Am J Ther 14: 414-6.
60. Sacerdote P. 2006. Opioids and the immune system. Palliat Med 20 (suppl 1). s9-15.
61. Sakurada T., Komatsu T., Sakurada S. 2005. Mechanisms of nociception evoked by intrathecal high-dose morphine. Neurotoxicology 26: 801-9.
62. Samadi P., Gregoire L., Bedard PJ 2003. Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems. Neuropharmacology 45: 954-63.
63. Sei Y., Yoshimoto K., McIntyre T., Skolnick P., Arora PK 1991. Morphine-induced thymic hypoplasia is glucocorticoid-dependent. J Immunol 146: 194-8.
64. Simon EJ 1991. Opioid receptors and endogenous opioid peptides. Med Res Rev 11: 357-74.
65. Singhal PC, Reddy K., Franki N., Sanwal V., Gibbons N. 1997. Morphine induces splenocyte apoptosis and enhanced mRNA expression of cathepsin-B. Inflammation 21: 609-17.
66. Stefano GB, Fricchione G., Goumon Y., Esch T. 2005. Pain, immunity, opiate and opioid compounds and health. Med Sci Monit 11: MS47-53.
67. Stefano GB, Goumon Y., Casares F., Cadet P., Fricchione GL, Rialas C., and others. 2000. Endogenous morphine. Trends Neurosci 23: 436-42.
68. Sueoka E., Sueoka N., Kai Y., Okabe S., Suganuma M., Kanematsu K., and others. 1998. Anticancer activity of morphine and its synthetic derivative, KT-90, mediated through apoptosis and inhibition of NF-kappaB activation. Biochem Biophys Res Commun 252: 566-70.
69. Suzuki S., Chuang LF, Doi RH, Chuang RY 2003. Morphine suppresses lymphocyte apoptosis by blocking p53-mediated death signaling. Biochem Biophys Res Commun 308: 802-8.
70. Tan TP, Algra PR, Valk J., Wolters EC 1994. Toxic leukoencephalopathy after inhalation of poisoned heroin: MR findings. AJNR Am J Neuroradiol 15: 175-8.
71. Turchan-Cholewo J., Liu Y., Gartner S., Reid R., Jie C., Peng X., and others. 2006. Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl. Neurobiol Dis 23: 109-19.
72. Ueda H., Inoue M., Mizuno K. 2003. New approaches to study the development of morphine tolerance and dependence. Life Sci 74 (2-3). 313-20.
73. Vallejo R., de Leon-Casasola O., Benyamin R. 2004. Opioid therapy and immunosuppression: a review. Am J Ther 11: 354-65.
74. Volkow ND, Valentine A., Kulkarni M. 1988. Radiological and neurological changes in the drug abuse patient: a study with MRI. J Neuroradiol 15: 288-93.
75. von Zastrow M., Svingos A., Haberstock-Debic H., Evans C. 2003. Regulated endocytosis of opioid receptors: cellular mechanisms and proposed roles in physiological adaptation to opiate drugs. Curr Opin Neurobiol 13: 348-53.
76. Weber M., Modemann S., Schipper P., Trauer H., Franke H., Illes P., and others. 2006. Increased polysialic acid neural cell adhesion molecule expression in human hippocampus of heroin addicts. Neuroscience 138: 1215-23.
77. Yin D., Woodruff M., Zhang Y., Whaley S., Miao J., Ferslew K., and others. 2006. Morphine promotes Jurkat cell apoptosis through pro-apoptotic FADD/P53 and anti-apoptotic PI3K/Akt/NF-kappaB pathways. J Neuroimmunol 174 (1-2). 101-7.
78. Yin DL, Ren XH, Zheng ZL, Pu L., Jiang LZ, Ma L., and others. 1997. Etorphine inhibits cell growth and induces apoptosis in SK-N-SH cells: involvement of pertussis toxin-sensitive G proteins. Neurosci Res 29: 121-7.
79. Zadina JE 2002. Isolation and distribution of endomorphins in the central nervous system. Jpn J Pharmacol 89: 203-8.
80. Zagon IS, McLaughlin PJ 2003. Opioids and the apoptotic pathway in human cancer cells. Neuropeptides 37: 79-88.
81. Zhang W., Hong JS, Kim HC, Zhang W., Block ML 2004. Morphinan neuroprotection: new insight into the therapy of neurodegeneration. Crit Rev Neurobiol 16: 271-302.
82. Zhao P., Huang Y., Zuo Z. 2006. Opioid preconditioning induces opioid receptor-dependent delayed neuroprotection against ischemia in rats. J Neuropathol Exp Neurol 65: 945-52.
83. Zohar O., Getslev V., Miller AL, Schreiber S., Pick CG 2006. Morphine protects for head trauma induced cognitive deficits in mice. Neurosci Lett 394: 239-42.